 |
 |
PharmaVOICE - September 2007 Success Beyond the Silos By Robin Robinson More and more pharmaceutical companies are breaking out of their siloed structure to reach their audiences more efficiently and more cost-effectively. Squeezed on all sides by regulatory requirements, physicians who spend little to no time with sales reps, consumers inundated with information clutter, and a less than adoring public, companies face stakes that are higher than ever. The pharmaceutical industry can no longer afford to be off-message -- not even once -- in this exceedingly competitive marketplace. This month's Forum discusses some of the challenges, best practices, and benefits witnessed by industry leaders who are acting as change agents in advancing the silo-busting trend... Sidebars: Sound Bites from the Field Anne Devereux, CEO, LyonHeart, New York. For more information, visit lyon-heart.com. Michael du Toit,Executive VP, Marketing and Client Services, Digitas Health, Philadelphia. For more information, visit digitashealth.com. Lisa Flaiz, VP, Group Director and National Pharmaceutical Practice Lead, Avenue A | Razorfish, Philadelphia. For more information, visit avenuea-razorfish.com. Tammy Hamilton, VP, Marketing and Communications, Science Oriented Solutions, Kennesaw, Ga. For more information, visit medicalaffairs.com. Bob Harrell, Director of Global eMarketing, Shire Pharmaceuticals, Wayne, Pa. For more information, visit shire.com. Robert Nauman, President, BioAdvisors Network, Cary, N.C. For more information, visit biopharmaadvisors.net. When the walls come down between R&D and marketing Thought Leaders Chris Bogan. CEO, Best Practices LLC, Chapel Hill, N.C.; Best Practices is a research, consulting, and publishing company operating in the field of best-practice benchmarking by studying the best business practices, operating tactics, and winning strategies of world-class organizations. For more information, visit best-in-class.com. Elio Evangelista. Research Team Leader, Cutting Edge Information, Durham, N.C.; Cutting Edge is a business intelligence firm that provides research reports for the pharmaceutical, biotechnology, and medical-devices industries. For more information, visit cuttingedgeinfo.com. Louisa Holland. President and Chief Operating Officer, Sudler & Hennessey, New York; Sudler & Hennessey is a global healthcare marketing and communications organization. For more information, visit sudler.com. Nikhil Nayak. Senior Product Director, Forest Laboratories, New York; Forest Laboratories is a U.S.-based pharmaceutical company delivering treatments for depression, hypertension, Alzheimer's disease, and alcohol abuse. For more information, visit frx.com. William O'Donnell. President and Chief Operating Officer, inVentiv Communications, Columbus, Ohio; inVentiv Communications is a global group of specialized communications companies that provide customized marketing solutions to the health and wellness industries, including many of the world's top pharmaceutical companies. For more information, visit inventivhealth.com. Paul Perreault. Executive VP, Worldwide Commercial Operations, CSL Behring Pharmaceutical, King Of Prussia, Pa.; CSL Behring, which operates in the plasma protein biotherapeutics industry, is dedicated to treating rare and serious diseases. For more information, visit cslbehring.com. Donald J.M. Phillips, Pharm.D. Principal and CEO, Vox Medica, Philadelphia; Vox Medica is an independent healthcare agency. For more information, visit voxmedica.com. David Stern. Executive VP, Metabolic Endocrinology, EMD Serono Inc., Rockland, Mass.; EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, is committed to discovering and developing medicines that address unmet medical needs, integrating innovative science with comprehensive patient support systems to improve lives. For more information, visit emdserono.com. Nancy Turett. Global President, Health, Edelman, New York; Edelman is an independent global public relations firm. For more information, visit edelmanpr.com.
|
